![](/img/cover-not-exists.png)
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial
Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M.T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., SabbLanguage:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2019.10.013
Date:
October, 2019
File:
PDF, 767 KB
english, 2019